Opendata, web and dolomites
H2020 projects about "biopsies"
The page lists 90 projects related to the topic "biopsies".
| # | |||
|---|---|---|---|
| 1 | SPENmr | Ultrafast Spatiotemporally-Encoding: A Superior Approach to Cancer Diagnosis by Non-Invasive Diffusion-Weighted MRI | 2015 |
| 2 | GLAM | Laser Multiplexed Biosensor | 2015 |
| 3 | MoTriColor | Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor) | 2015 |
| 4 | InSPECT | Integrated Spectrometers for Spectral Tissue Sensing | 2015 |
| 5 | VIVOIMAG | Multimodal imaging of the in vivo fate of bone transplants | 2015 |
| 6 | PULVAD | Pressure Unloading LVAD: An Explantable and Cost-Effective Bridge to Recovery in Heart Failure | 2015 |
| 7 | breast cancer dormancy | Molecular characterisation of a clinical model of estrogen receptor-positive breast cancer dormancy | 2015 |
| 8 | IPEIBD | Identification of promoters and enhancers specific for inflammatory bowel disease and its subtypes | 2015 |
| 9 | HYscreen | A fast, cost-effective breath analysis technology for Helicobacter pYlori screening at both large and small scale. | 2015 |
| 10 | PREVENT | Prostate cancer extracellular vesicles as biomarkers for nanomedicine treatment | 2015 |
| 11 | ProCanEx | Prostate cancer diagnostic assay based on protein kinase activity profiling in exosomes | 2015 |
| 12 | DERMAE | Clinical research for the validation of a non-invasive medical imaging device for dermatological diagnoses | 2015 |
| 13 | GLIOMARK | Validation of blood-brain-barrier permeability as a glioma biomarker by means of the radiotracer 99mTc-tetrofosmin and single-photon emission computer tomography | 2015 |
| 14 | IXSI3D | Translating Hybrid Imaging for Interventions: Intra-operative Guidance and Evaluation using 2D and 3D Interventional X-ray Scintigraphy Imaging | 2015 |
| 15 | VESCEL | Vascular Engineering on chip using differentiated Stem Cells | 2015 |
| 16 | CellScreenChip | All-in-One Cell Screening Chip: Device for Affordable High-Throughput Cell Screenings | 2015 |
| 17 | PreventStoCan | Understanding microbe-induced stomach cancer – the key to a workable strategy for worldwide prevention | 2016 |
| 18 | CONSALT | CONtrast through metal-enriched polymer SALTs: novel contrast agents for dual-energy micro-computed tomography | 2016 |
| 19 | GallBiome | Characterization of the Human Gallbladder Microbiome | 2016 |
| 20 | ProstaPalp | Feasibility study to evaluate a novel prostate cancer diagnostic | 2016 |
| 21 | 2MoveMate4Melanoma | A treatment for BRAF inhibitor resistant melanoma | 2016 |
| 22 | CLONCELLBREAST | CLONAL AND CELLULAR HETEROGENEITY OF BREAST CANCER AND ITS DYNAMIC EVOLUTION WITH TREATMENT | 2017 |
| 23 | SMILED | Skeletal Muscle Inflammation: ambivalent roles in Exercise and Diabetes | 2016 |
| 24 | AGLARIS | AGLARIS: The First Fully-automated Bioreactor for Large Scale Human Stem Cell Production through an Iterative Process. | 2016 |
| 25 | GlioDx | GlioDx - Blood platelet-based monitoring and treatment optimisation for glioblastoma patients | 2016 |
| 26 | uPROPHET | uPROPHET: Urinary PROteomics in Predicting HEart Transplantation outcomes | 2016 |
| 27 | TiMaScan | Recirculated tissue macrophages (TiMa) in blood: Novel approach to early diagnosis and treatment monitoring in oncology | 2016 |
| 28 | iGBMavatars | Glioblastoma Subtype Avatar models for Target Discovery and Biology | 2017 |
| 29 | TKI resistance | Resistance mechanisms to tyrosine kinase inhibitors in solid tumors | 2016 |
| 30 | LungCARD | Blood test for clinical therapy guidance of non-small cell lung cancer patients | 2017 |
| 31 | SmartGuide | Smart Biopsy Tool for Real-Time Cancerous Cell Characterization at the Tip of the Needle | 2017 |
| 32 | ONCOmetENHANCERS | Elucidating the Role of Enhancer Methylation Variation in Cancer and Developing Enhancer-based Markers and Targets for Precision Medicine | 2017 |
| 33 | IMMUNO_CRC | Microbiota-immune interaction in colorectal cancer | 2017 |
| 34 | PlateletLiquidBiopsy | Exploring the cellular heterogeneity underlying 'tumor-educated' platelets | 2017 |
| 35 | CTCapture_2.0 | Advanced platform for profiling of therapeutic targets and functional analysis of circulating tumour cells in cancer patients | 2017 |
| 36 | OVO-GROWTH | Oogenesis spotlighted: making mature human oocytes | 2017 |
| 37 | HoldCancerBack | What Holds Cancer Cells Back? | 2017 |
| 38 | ELBA | European Liquid Biopsies Academy - Towards widespread clinical application of blood- based diagnostic tools | 2018 |
| 39 | HIT-CF | Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond) | 2018 |
| 40 | LIMA | Liquid biopsies and Imaging for improved cancer care | 2018 |
| 41 | MyPeBS | International Randomized Study Comparing personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70 | 2018 |
| 42 | OneRNA4Bladder | Non invasive Cell Based Liquid Biopsy Platform for Bladder Cancer | 2017 |
| 43 | SDS-OmiProbe | Revolutionary opto-biological methodology for aggressive HER2 cancer | 2017 |
| 44 | PATHOLYTIX-GI | PATHOLYTIX: Using Artificial Intelligence to Transform Clinical Diagnostic Pathology | 2017 |
| 45 | EXACT-dna | EXtended Analysis of Circulating Tumour DNA to improve cancer management strategies | 2017 |
| 46 | ProstOmics | 'Tissue is the issue': a multi-omics approach to improve prostate cancer diagnosis | 2018 |
| 47 | CTC-MAL | Isolation of rare circulating tumor cells | 2018 |
| 48 | MAXIBONE | Personalised maxillofacial bone regeneration | 2018 |
| 49 | IMMUNOMARK | Omics integration for precision cancer immunotherapy | 2018 |
| 50 | cureCD | Function of long non-coding RNA in Crohn Disease Ulcer Pathogenesis | 2018 |
| 51 | DYNAFLUORS | Dynamic Activatable Fluorophores | 2018 |
| 52 | SenPET | Innovative cancer management: First in human senescence imaging | 2018 |
| 53 | SHINE | Self-Healthcare for breast cancer detection using an INtegrated paper-based Electrochemical device | 2019 |
| 54 | MECoCaM | Human gut Microbiome, gene Expression and Colorectal Cancer: Assigning causal roles from a novel Mendelian randomization perspective. | 2018 |
| 55 | SEQURE | Targeted complete next-generation sequencing for companion diagnostics and personalized treatment of cancer | 2018 |
| 56 | CERVINO | Can human embryo-released extracellular vesicles govern endometrial receptivity and inform on vanguard embryo diagnostics and fertility therapeutics? | 2018 |
| 57 | HypoSkin | Unique breakthrough ex vivo human skin model to predict efficacy and toxicity of subcutaneous drugs | 2018 |
| 58 | SCOPIO | High-resolution, all-digital microscope that applies computational methods to bring revolutionary benefits of digital microscopy to small and medium sized laboratories | 2018 |
| 59 | CytoPro | A breakthrough cancer diagnostic instrument to save 3000 years of human lives annually and up | 2018 |
| 60 | BiopSense | Proof of concept and pre-commercialisation of personalised liquid biopsies in cancer therapy | 2018 |
| 61 | SCIPER | Studying Cancer Individuality by Personal and Predictive Drug Screening and Differential OMICs | 2018 |
| 62 | Andrea | A Novel Detection protocols for REliable prostate cancer Assays | 2018 |
| 63 | Nevada | Diagnostics device for rapid testing of prostate cancer at Point-of-care | 2018 |
| 64 | AI-MICADIS | Artificial Intelligence System for Multi-Cancer Detection Support | 2019 |
| 65 | GlyCan | Innovative Glycan-based analysis for Cancer diagnostics | 2019 |
| 66 | CANCEREVO | Deciphering and predicting the evolution of cancer cell populations | 2019 |
| 67 | Capsulight | The first ingestible capsule for eradicating Helicobacter pylori infection through photodynamic therapy | 2019 |
| 68 | IMaP | Imaging tumor vessels as a marker for p53 mutation status in cancer | 2020 |
| 69 | AR-DDR | Co-targeting androgen receptor signalling and DNA damage repair for precision therapy in advanced prostate cancer | 2019 |
| 70 | StopIG | Translating fundamental insights in podocyte metabolism and cell cycle regulation: development of a new treatment for Stopping crescentic Immune Glomerulonephritis | 2019 |
| 71 | DIE_CKD | Deciphering intrarenal communication to unvail mechanisms of chronic kidney diseases | 2019 |
| 72 | Adductomics | Novel DNA adductomics methodological developments for research in colon cancer | 2019 |
| 73 | BRAIN-MATCH | Matching CNS Lineage Maps with Molecular Brain Tumor Portraits for Translational Exploitation | 2019 |
| 74 | OCTAV | A novel approach to non-invasive and personalized skin cancer diagnosis | 2019 |
| 75 | ONCOTECT | Early detection of tumor DNA in liquid biopsies as a biomarker of cancer recurrence | 2019 |
| 76 | IMPACT | Improving DNA Analysis for Correct Healthcare | 2019 |
| 77 | INJURMET | Impact of tissue injury induced by diagnostic biopsies and surgery on cancer metastasis | 2019 |
| 78 | IRIS Phase-1 | A revolutionary blood test to easily diagnose and prevent deadly complications of organs and tissue transplants. | 2019 |
| 79 | LIVELMIA | Innovative assay for microRNAs analysis | 2019 |
| 80 | SONOBOTS | Acousto-Magnetic Micro/Nanorobots for Biomedical Applications | 2019 |
| 81 | PROSCOPE | Point-of-care instrument for diagnosis and image-guided intervention of Colo-Rectal Cancer | 2020 |
| 82 | PROST | Autonomous Prostate Biopsy | 2019 |
| 83 | CUDI | Implementation of contrast-ultrasound dispersion imaging for better prostate cancer care | 2020 |
| 84 | NIPCT | Non-invasive prenatal diagnostics – Isolation of circulating trophoblast cells using a malaria protein | 2020 |
| 85 | PROSKit | Prostate cancer urinary diagnostic kit based on RNA biomarkers | 2020 |
| 86 | oncNGS | NGS diagnostics in 21st century oncology: the best, for all, at all times | 2020 |
| 87 | ImmUniverse | Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies | 2020 |
| 88 | PROSTATOR | Reliable urinary test for the diagnosis of prostate cancer | 2020 |
| 89 | ROSETTA | Deciphering the Role of aberrant glycOSylation in the rEsponse to Targeted TherApies for breast cancer | 2020 |
| 90 | TARGETOF | Mass cytometry nanotools for intracellular target engagement. Towards precision medicine. | 2021 |